These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35977671)

  • 1. IMPORTANCE of PRETREATMENT 18F-FDG PET/CT TEXTURE ANALYSIS in PREDICTING EGFR and ALK MUTATION in PATIENTS with NON-SMALL CELL LUNG CANCER.
    Agüloğlu N; Aksu A; Akyol M; Katgı N; Doksöz TÇ
    Nuklearmedizin; 2022 Dec; 61(6):433-439. PubMed ID: 35977671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of
    Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between 18F-FDG PET/CT radiometabolic markers and EGFR mutation, positive ALK Expression in patients with non-small cell lung cancer.
    Gayaf M; Anar C; Aksel N; Erbaycu AE; Koporal H
    Tuberk Toraks; 2021 Dec; 69(4):437-448. PubMed ID: 34957737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
    Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
    Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Ruan D; Fang J; Teng X
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
    Agüloğlu N; Aksu A; Unat DS
    Nucl Med Commun; 2023 Apr; 44(4):302-308. PubMed ID: 36756766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer.
    Agazzi GM; Ravanelli M; Roca E; Medicina D; Balzarini P; Pessina C; Vermi W; Berruti A; Maroldi R; Farina D
    Radiol Med; 2021 Jun; 126(6):786-794. PubMed ID: 33512651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between combining
    Ruan M; Liu L; Wang L; Lei B; Sun X; Chang C; Shen Y; Xie W
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1183-1197. PubMed ID: 31897590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting EGFR mutation, ALK rearrangement, and uncommon EGFR mutation in NSCLC patients by driverless artificial intelligence: a cohort study.
    Tan X; Li Y; Wang S; Xia H; Meng R; Xu J; Duan Y; Li Y; Yang G; Ma Y; Jin Y
    Respir Res; 2022 May; 23(1):132. PubMed ID: 35624472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.
    Liu A; Han A; Zhu H; Ma L; Huang Y; Li M; Jin F; Yang Q; Yu J
    Oncotarget; 2017 May; 8(20):33736-33744. PubMed ID: 28422710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
    Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K
    Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of multi-center
    Zuo Y; Liu L; Chang C; Yan H; Wang L; Sun D; Ruan M; Lei B; Xia X; Xie W; Song S; Huang G
    Med Phys; 2024 Jul; 51(7):4872-4887. PubMed ID: 38285641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric and radiomics assessment of lesions with incidental [18F]FDG uptake in the colon: a retrospective radiomics study.
    Agüloğlu N; Acar Akkaya E; Binicier ÖB
    Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):145-151. PubMed ID: 34664824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
    Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
    Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
    Park SB; Kim KU; Park YW; Hwang JH; Lim CH
    Nucl Med Commun; 2023 Feb; 44(2):161-168. PubMed ID: 36458424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer.
    Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.